These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes. Schrottmaier WC; Kral JB; Badrnya S; Assinger A Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241 [TBL] [Abstract][Full Text] [Related]
4. The Function and Regulation of Platelet P2Y12 Receptor. Li X; Zhang G; Cao X Cardiovasc Drugs Ther; 2023 Feb; 37(1):199-216. PubMed ID: 34319489 [TBL] [Abstract][Full Text] [Related]
5. Effect of P2Y12 inhibitors on inflammation and immunity. Thomas MR; Storey RF Thromb Haemost; 2015 Aug; 114(3):490-7. PubMed ID: 26156883 [TBL] [Abstract][Full Text] [Related]
6. Structure, Pharmacology and Roles in Physiology of the P2Y von Kügelgen I Adv Exp Med Biol; 2017; 1051():123-138. PubMed ID: 28921447 [TBL] [Abstract][Full Text] [Related]
7. Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines. Nylander S; Schulz R Br J Pharmacol; 2016 Apr; 173(7):1163-78. PubMed ID: 26758983 [TBL] [Abstract][Full Text] [Related]
8. The role of P2Y₁₂ receptor and activated platelets during inflammation. Liverani E; Kilpatrick LE; Tsygankov AY; Kunapuli SP Curr Drug Targets; 2014; 15(7):720-8. PubMed ID: 24845219 [TBL] [Abstract][Full Text] [Related]
9. The Signaling Pathway of the ADP Receptor P2Y Entsie P; Kang Y; Amoafo EB; Schöneberg T; Liverani E Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047682 [TBL] [Abstract][Full Text] [Related]
14. The role of P2Y12 receptor inhibition in ischemic stroke on microglia, platelets and vascular smooth muscle cells. Li F; Xu D; Hou K; Gou X; Li Y J Thromb Thrombolysis; 2020 Nov; 50(4):874-885. PubMed ID: 32248335 [TBL] [Abstract][Full Text] [Related]
16. Use of antiplatelet agents in sepsis: a glimpse into the future. Akinosoglou K; Alexopoulos D Thromb Res; 2014 Feb; 133(2):131-8. PubMed ID: 24103487 [TBL] [Abstract][Full Text] [Related]
17. SAR216471, an alternative to the use of currently available P2Y₁₂ receptor inhibitors? Delesque-Touchard N; Pflieger AM; Bonnet-Lignon S; Millet L; Salel V; Boldron C; Lassalle G; Herbert JM; Savi P; Bono F Thromb Res; 2014 Sep; 134(3):693-703. PubMed ID: 25064036 [TBL] [Abstract][Full Text] [Related]
18. P2Y12 receptor: platelet thrombus formation and medical interventions. Moheimani F; Jackson DE Int J Hematol; 2012 Nov; 96(5):572-87. PubMed ID: 23054651 [TBL] [Abstract][Full Text] [Related]
19. G-protein-coupled receptors signaling pathways in new antiplatelet drug development. Gurbel PA; Kuliopulos A; Tantry US Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):500-12. PubMed ID: 25633316 [TBL] [Abstract][Full Text] [Related]
20. A critical appraisal of the functional evolution of P2Y12 antagonists as antiplatelet drugs. Fayaz SM; Rajanikant GK Curr Pharm Des; 2012; 18(12):1625-34. PubMed ID: 22360514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]